輸入代號或公司名稱後按 Enter
ORGO

Organogenesis Holdings Inc.

-0.01 (-1.08%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834
1.38USD136K成交股數177M市值本益比(近四季)0.4股價營收比-56.7%營收年增(近四季)2026-11-05下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收43.8M-50%37.2M-71%151M+31%101M-22%86.7M-21%127M+17%115M-2%130M+21%110M109M117M108M
營業成本23.7M31.1M26.8M29.2M28.7M25.8M26.3M26.6M
毛利63.0M-23%95.6M+16%88.4M-3%101M+25%81.3M82.7M91.0M81.0M
毛利率72.6%75.5%76.7%77.6%73.9%76.2%77.6%75.3%
研發費用18.3M15.2M13.2M10.4M10.6M11.5M10.3M15.6M12.8M10.5M10.9M11.2M
銷售管理費用54.0M65.2M79.7M73.8M72.5M73.9M71.8M76.5M72.3M64.2M70.3M73.8M
營業利益−51.0M+91%−68.9M-774%20.7M+232%−12.6M-9%−26.7M+594%10.2M+27%6.2M-36%−13.9M+247%−3.9M8.1M9.7M−4.0M
營業利益率-116.5%-185.1%13.7%-12.5%-30.9%8.1%5.4%-10.7%-3.5%7.4%8.3%-3.7%
稅後淨利−96.3M+411%−53.2M-789%21.6M+75%−9.4M-45%−18.8M+797%7.7M+144%12.3M+132%−17.0M+474%−2.1M3.2M5.3M−3.0M
淨利率-220.0%-142.8%14.3%-9.3%-21.7%6.1%10.7%-13.1%-1.9%2.9%4.5%-2.8%
稀釋 EPS-0.77+353%-0.44-980%0.11+22%-0.10-23%-0.17+750%0.05+150%0.09+125%-0.13+550%-0.020.020.04-0.02
稀釋股數129M128M131M127M126M132M134M133M132M133M133M131M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金46.1M91.4M63.7M73.1M110M136M94.3M89.9M88.6M98.2M88.9M88.7M
應收帳款101M117M169M120M103M110M101M106M96.1M89.3M93.6M92.0M
存貨29.3M28.4M39.6M33.0M29.3M26.2M27.0M26.9M27.7M27.9M25.4M25.5M
總資產406M520M510M461M467M498M446M443M458M463M450M446M
有息負債62.3M63.8M65.2M68.0M69.4M70.3M
總負債118M139M124M99.9M99.3M113M168M180M180M186M179M182M
股東權益148M245M255M233M243M263M279M264M278M277M271M264M
負債比29.1%26.7%24.3%21.7%21.3%22.6%37.6%40.5%39.4%40.2%39.8%40.9%
淨現金(現金 − 有息負債)32.0M26.2M23.5M30.3M19.5M18.4M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流21.1M−19.9M+96%−10.2M−5.1M
資本支出3.1M3.6M2.2M7.6M
自由現金流18.0M−23.6M+90%−12.4M−12.6M
折舊攤銷4.2M3.4M3.6M3.6M3.4M3.1M2.5M2.2M
買回庫藏股
現金股利
自由現金流率48.3%-27.2%-11.3%-11.7%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

產品/服務2025 年度 · 564M
產品563M99.8%+16.8%
Grant1.1M0.2%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025564M+17.0%37.0M6.6%0.15−24.5M
FY2024482M+11.3%900K0.2%-0.014.2M
FY2023433M-3.9%4.9M1.1%0.046.6M
FY2022451M-3.5%15.5M3.4%0.12−9.0M
FY2021467M+38.2%94.2M20.2%0.7030.8M
FY2020338M+29.6%17.2M5.1%0.15−12.2M
FY2019261M+34.9%−38.7M-14.8%-0.42−39.5M
FY2018193M−64.8M-33.5%-0.94−62.5M